Clinical Study Results
The websites listed at the end of this summary may have other information about the
adverse reactions that happened during this study.
How many participants had serious adverse reactions?
There were 39.1% of participants who had serious adverse reactions during the study.
This was 9 out of 23 participants.
There were 4.3% of participants who died during the study because of adverse
reactions. This was 1 out of 23 participants. This participant was in Group 1 and died
from the serious adverse reaction of liver failure.
The table below shows the serious adverse reactions that happened during the study.
Serious adverse reactions during the study
Group 1 Group 2
(out of 3 participants) (out of 20 participants)
Swelling in the lungs 33.3% (1) 0.0% (0)
Serious pain in the legs 33.3% (1) 0.0% (0)
Liver failure 33.3% (1) 0.0% (0)
High risk of developing a fatal liver
33.3% (1) 0.0% (0)
injury
Blockage in the arteries 0.0% (0) 5.0% (1)
Large decrease in amount of
white blood cells, which can make
0.0% (0) 5.0% (1)
it difficult for the body to fight
infections
Negative reaction in the body
0.0% (0) 5.0% (1)
when infusion was given
Serious constipation 0.0% (0) 5.0% (1)
Serious diarrhea 0.0% (0) 5.0% (1)
Serious difficulty in breathing 0.0% (0) 5.0% (1)
Serious fever 0.0% (0) 5.0% (1)
Serious vomiting 0.0% (0) 5.0% (1)
Swelling from a low amount of
0.0% (0) 5.0% (1)
white blood cells
Swelling in the digestive system 0.0% (0) 5.0% (1)
Swelling in the liver 0.0% (0) 5.0% (1)
Swelling in the throat from an
0.0% (0) 5.0% (1)
infection
9